195. Noonan syndrome Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 25 / Drugs : 23 - (DrugBank : 5) / Drug target genes : 2 - Drug target pathways : 9
Noonan syndrome and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
| ID | Diseases (Sorted by score) | Score |
|---|---|---|
| 195 | Noonan syndrome | - |
| 13 | Multiple sclerosis/Neuromyelitis optica | 2.000 |
| 299 | Cystic fibrosis | 2.000 |
| 46 | Malignant rheumatoid arthritis | 2.000 |
| 96 | Crohn disease | 2.000 |
| 265 | Lipodystrophy | 2.000 |
| 191 | Werner syndrome | 1.000 |